Access Statistics for Fabio Pammolli

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development 0 0 0 0 1 3 8 186
A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development 1 2 3 51 2 7 20 195
A Comparison of U.S. And European University-Industry Relations in the Life Sciences 0 0 0 0 1 1 2 354
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 2 61 0 1 8 292
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 8 1 2 3 63
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 3 0 0 0 32
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 5 0 0 1 73
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 3 0 0 1 57
Access to Medicines and European Market Integration 0 1 1 25 2 4 6 52
Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione 0 0 0 5 0 1 2 55
Assessing financial distress dependencies in OTC markets: a new approach by Trade Repositories data 0 2 3 22 1 4 8 33
Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement 1 1 2 145 1 1 6 466
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks 0 0 1 21 0 0 2 132
Co-evolution of Organizational Forms and Technology 0 0 0 0 0 0 0 244
Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry 0 0 0 233 2 2 2 447
Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali 0 0 1 11 0 1 4 67
Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy 0 0 0 44 0 0 5 120
Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo 0 0 2 47 0 2 9 161
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure 1 1 3 136 2 3 14 470
Federalismo e riparto del Fsn-2011: Much Ado About Nothing? 0 0 1 13 0 1 9 153
Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN 0 0 0 12 0 2 4 80
Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale 0 0 1 16 0 1 9 61
Global Competitiveness in Pharmaceuticals: A European Perspective 0 1 2 108 0 2 6 344
I Farmaci Oncologici in Italia: innovazione e sostenibilità economica 0 0 3 43 0 1 10 178
I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini 0 0 2 16 0 2 12 76
I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009 0 0 1 16 1 2 12 77
I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età 2 5 6 33 2 6 12 102
I numeri del federalismo: una simulazione per la sanità 0 0 1 9 0 1 10 63
I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale 0 0 1 11 0 1 8 86
Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato 0 0 2 14 2 3 15 99
Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato 0 0 0 6 0 1 4 41
Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico 0 0 0 15 1 3 12 92
In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale 0 1 3 15 0 2 10 78
Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale 0 0 1 7 0 2 4 58
Innovation and Corporate Dynamics: A Theoretical Framework 0 0 0 66 0 0 3 114
Innovation and Corporate Dynamics: A Theoretical Framework 1 1 4 147 1 1 11 239
Innovation and Corporate Growth in the Evolution of the Drug Industry 0 1 2 419 1 5 19 892
Introduzione. Liberalizzazioni e concorrenza in Italia 0 0 0 24 0 0 5 121
L'integrazione pubblico-privato in sanità e assistenza alla persona 0 1 2 14 0 3 10 69
La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro 0 0 0 12 0 0 3 62
La Sostenibilità dei Sistemi Sanitari Regionali 0 1 3 23 0 2 11 93
La Sostenibilità dei Sistemi Sanitari Regionali 0 0 1 31 0 2 8 114
La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato 0 0 3 23 0 1 13 238
La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di datore di lavoro 0 0 1 11 0 1 4 56
La regolamentazione delle farmacie in Italia 0 0 0 23 0 4 11 100
La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche 0 0 3 10 0 4 15 74
La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica 0 0 1 16 0 1 7 63
La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale 0 0 1 10 1 2 14 79
La spesa sanitaria delle Regioni in Italia - Saniregio 2015 0 0 5 63 1 11 40 216
La spesa sanitaria delle Regioni in Italia - Saniregio 3 0 3 3 48 0 3 13 178
La spesa sanitaria delle Regioni in Italia - Saniregio2017 3 4 10 40 5 9 36 125
La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio 3 5 15 83 7 11 39 251
Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011 0 0 3 45 1 3 18 160
Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM 0 1 1 13 0 1 9 79
Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030 1 3 5 51 1 4 16 164
Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria 0 0 2 9 0 2 11 74
Market Structure and Drug Innovation 0 0 0 29 0 0 4 120
Medical Devices Competitiveness and Impact on Public Health Expenditure 1 2 9 165 2 8 35 619
Medical Devices: Competitiveness and Impact on Public Health Expenditure 1 1 2 24 3 5 15 116
Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale 0 1 3 7 0 3 7 60
Networks Dynamics in the Pharmaceutical Industry 0 0 0 1 0 0 0 249
Networks of innovators within and across borders. Evidence from patent data 0 0 0 107 1 1 7 212
Nuove politiche per l'innovazione nel settore delle scienze della vita 0 0 0 6 0 1 7 71
Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo 0 0 1 6 0 1 4 54
On Firm Growth in Networks 0 0 1 19 0 0 1 104
On Size and Growth of Business Firms 0 0 0 32 0 2 8 318
Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato 0 0 0 7 0 1 3 48
Patent Disclosure and R&D Competition in Pharmaceuticals 0 1 2 106 2 8 11 172
Patent Disclosure and R&D Competition in Pharmaceuticals 0 0 1 117 2 3 6 298
Patent Value and R&D Competition 0 0 0 1 0 0 0 24
Peer-Group Detection of Banks and Resilience to Distress 0 0 0 12 1 2 7 44
Preferential attachment and growth dynamics in complex systems 0 0 0 17 0 0 2 98
Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals 0 0 4 247 0 2 8 508
R&D, Within and Between Patent Competition in the Pharmaceutical Industry 1 1 3 162 1 1 5 340
Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica 0 0 0 12 2 3 15 80
Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano 1 1 4 17 2 3 8 65
Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione 0 0 0 8 0 1 4 63
Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine 0 0 1 8 0 1 7 59
Statistical Properties of Business Firms Structure and Growth 0 0 1 16 0 0 3 76
Structure of Business Firm Networks and Scale-Free Models 0 0 0 52 0 0 1 230
Structure of Business Firm Networks and Scale-Free Models 0 0 0 11 1 2 2 87
Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata 1 3 4 31 1 5 9 110
Systemic importance of financial institutions: from a global to a local perspective? A network theory approach 0 0 0 90 1 2 6 109
Systemic importance of financial institutions: regulations, research, open issues, proposals 0 0 3 46 0 0 11 178
Systemic risk and banking regulation: some facts on the new regulatory framework 0 0 1 132 2 3 9 201
Technological Regimes and the Growth of Networks An Empirical Analysis 0 0 0 129 2 4 9 344
The Accounting Network: how financial institutions react to systemic crisis 0 0 0 26 0 0 1 19
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 0 0 0 16 1 2 3 98
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 0 3 9 153 24 87 251 1,371
The Multipillar System for Health Care Financing: Thirteen Good Reasons for Open Capitalisation Funds, Covering both Pension and Health Care Provisions 0 0 0 30 1 3 7 75
The Nature and the Extent of the Market for Technology in Biopharmaceuticals 0 0 0 44 1 1 6 164
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 27 0 0 1 73
The Size Variance Relationship of Business Firm Growth Rates 1 1 1 31 1 1 1 78
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 37 0 0 0 92
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 0 3 56 0 0 6 185
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 0 1 1 2 3 7 28
The Value of Failures in Pharmaceutical R&D 0 0 0 30 2 5 9 117
The evolution of networks of innovators within and across borders: Evidence from patent data 1 2 5 139 7 8 13 169
The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data 1 2 2 36 1 5 9 42
The productivity crisis in pharmaceutical R&D 0 0 5 161 2 8 23 443
Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions 0 1 2 98 3 9 23 194
Total Working Papers 21 53 175 4,837 105 326 1,128 16,853


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development 1 2 4 31 2 12 22 119
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 0 9 2 2 3 75
A generalized preferential attachment model for business firms growth rates 0 0 0 6 1 2 2 26
A generalized preferential attachment model for business firms growth rates 0 0 0 6 0 0 0 16
Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data 0 2 4 10 1 5 12 45
Dynamic competition in pharmaceuticals 0 0 0 10 1 1 1 33
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 0 0 0 20 0 0 1 97
Innovation and corporate growth in the evolution of the drug industry 0 1 6 129 2 3 27 443
Intellectual property, technological regimes and market dynamics 0 0 1 11 0 0 6 35
La distribuzione dei farmaci tra progetti di riforma e incertezze 0 0 0 16 1 1 10 158
Learning from successes and failures in pharmaceutical R&D 0 0 3 11 3 6 19 59
On Innovation, Instability, and Growth. A Review and an Interpretative Framework 0 0 0 7 0 0 4 24
On firm growth in networks 0 0 0 66 0 2 9 170
On size and growth of business firms 0 0 0 5 0 1 5 20
On the size distribution of business firms 0 0 1 75 2 2 6 228
Patent disclosure and R&D competition in pharmaceuticals 0 1 1 62 0 3 5 288
Technological Regimes and the Growth of Networks: An Empirical Analysis 0 0 0 30 0 1 6 116
Technological change and network dynamics: Lessons from the pharmaceutical industry 1 2 6 175 1 7 13 458
The Evolution of Knowledge and the Dynamics of an Industry Network 0 0 1 77 2 4 8 297
The Growth of Business Firms: Facts and Theory 0 0 2 108 0 1 5 626
The changing boundaries of system companies 0 0 0 3 0 0 1 23
The evolution of networks of innovators within and across borders: Evidence from patent data 0 1 2 14 0 2 6 48
The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis 0 0 1 41 1 4 5 121
The price of pharmaceutical products in Italy. On some recent trends 0 0 0 10 1 1 2 28
The sustainability of European health care systems: beyond income and aging 0 0 1 23 1 1 5 84
Total Journal Articles 2 9 33 955 21 61 183 3,637


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences 0 0 3 7 1 1 6 19
Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry 0 1 1 7 1 2 4 16
Total Chapters 0 1 4 14 2 3 10 35


Statistics updated 2019-10-05